|
|
/
Browsing by Author Burke, A.J.
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) | | Jun-2014 | 3-Hydroxypyrrolidine and (3,4)-dihydroxypyrrolidine derivatives: inhibition of rat intestinal α-glucosidase | Carreiro, E. P.; Louro, P.; Adriano, G; Guedes, R. A.; Vannuchic, N.; Costa, A. R.; Antunes, C. M.; Guedes, R. C.; Burke, A.J. |
| 2022 | Evaluation of Chromane Derivatives: Promising Privileged Scaffolds for Lead Discovery within Alzheimer’s Disease | Moutayakine, A.; Marques, C.S.; López, O.; Bagetta, D.; Leitzbach, L.; Hagenow, S.; Carreiro, E.P.; Stark, H.; Alcaro, S.; Fernández-Bolaños, J.G.; Burke, A.J. |
| 2022 | Isatina: “Bloco de Construção” Promissor no Desenvolvimento de Novos Fármacos | Marques, C.S.; Burke, A.J. |
| 2022 | N-1,2,3-Triazole-Isatin Derivatives: Anti-proliferation effects and target identification in solid tumour cell lines | Busto, N.; Leitão-Castro, J.; García-Sosa, A.T.; Cadete, F.; Marques, C.S.; Freitas, R.; Burke, A.J. |
| 2022 | N-1,2,3-Triazole-Isatin derivatives in lymphoma cell lines | Gaudio, E.; Tarantelli, C.; Marques, C.S.; Ekeh, H.; Carmelo, M.; Burke, A.J.; Bertoni, F. |
| 2022 | Survey of New Small Molecule Isatin-based Oxindole Hybrids as Multi-Targeted Drugs for the Treatment of Alzheimer’s Disease | Marques, C.S.; López, O.; Leitzbach, L.; Fernández-Bolaños, J.G.; Stark, H.; Burke, A.J. |
Showing results 1 to 6 of 6
|
